Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug
Meijer, E., Gansevoort, R. T., de Jong, P. E., van der Wal, A. M., Leonhard, W. N., de Krey, S. R., van den Born, J., Mulder, G. M., van Goor, H., Struck, J., de Heer, E., Peters, D. J. M.
Published in Nephrology, dialysis, transplantation (01.08.2011)
Published in Nephrology, dialysis, transplantation (01.08.2011)
Get full text
Journal Article